Skip to main content
. 2022 Sep 13;12:914385. doi: 10.3389/fonc.2022.914385

Figure 4.

Figure 4

Subgroup analysis for progression-free survival and overall survival stratified by Child–Pugh class A (A, B) and B (C, D). T+S, transarterial chemoembolization+sorafenib; T+S+ICIs, transarterial chemoembolization+sorafenib+immune checkpoint inhibitors.